vs

Side-by-side financial comparison of Montauk Renewables, Inc. (MNTK) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Montauk Renewables, Inc. is the larger business by last-quarter revenue ($43.4M vs $37.2M, roughly 1.2× Organogenesis Holdings Inc.). On growth, Montauk Renewables, Inc. posted the faster year-over-year revenue change (56.7% vs -57.1%). Over the past eight quarters, Montauk Renewables, Inc.'s revenue compounded faster (5.8% CAGR vs -46.5%).

Montauk Renewables, Inc. is a US-based renewable energy firm specializing in capturing and converting biogenic methane from landfills and agricultural waste into renewable natural gas (RNG) and low-carbon electricity. It serves utility, commercial, and industrial customers across North America, with operations focused on advancing decarbonization and sustainable energy transition goals.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

MNTK vs ORGO — Head-to-Head

Bigger by revenue
MNTK
MNTK
1.2× larger
MNTK
$43.4M
$37.2M
ORGO
Growing faster (revenue YoY)
MNTK
MNTK
+113.7% gap
MNTK
56.7%
-57.1%
ORGO
Faster 2-yr revenue CAGR
MNTK
MNTK
Annualised
MNTK
5.8%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MNTK
MNTK
ORGO
ORGO
Revenue
$43.4M
$37.2M
Net Profit
$2.5M
Gross Margin
30.8%
Operating Margin
-3.8%
-185.1%
Net Margin
5.7%
Revenue YoY
56.7%
-57.1%
Net Profit YoY
129.5%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MNTK
MNTK
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$43.4M
$225.6M
Q3 25
$45.3M
$150.9M
Q2 25
$45.1M
$101.0M
Q1 25
$42.6M
$86.7M
Q4 24
$27.7M
$126.7M
Q3 24
$65.9M
$115.2M
Q2 24
$43.3M
$130.2M
Net Profit
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
$2.5M
$43.7M
Q3 25
$5.2M
$21.6M
Q2 25
$-5.5M
$-9.4M
Q1 25
$-464.0K
$-18.8M
Q4 24
$-8.5M
$7.7M
Q3 24
$17.0M
$12.3M
Q2 24
$-712.0K
$-17.0M
Gross Margin
MNTK
MNTK
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
43.8%
76.7%
Q2 24
15.6%
77.6%
Operating Margin
MNTK
MNTK
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-3.8%
28.1%
Q3 25
9.8%
13.7%
Q2 25
-5.2%
-12.5%
Q1 25
1.0%
-30.9%
Q4 24
-35.5%
8.1%
Q3 24
34.4%
5.4%
Q2 24
2.0%
-10.7%
Net Margin
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
5.7%
19.4%
Q3 25
11.5%
14.3%
Q2 25
-12.2%
-9.3%
Q1 25
-1.1%
-21.7%
Q4 24
-30.5%
6.1%
Q3 24
25.9%
10.7%
Q2 24
-1.6%
-13.1%
EPS (diluted)
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
$0.01
$0.31
Q3 25
$0.04
$0.11
Q2 25
$-0.04
$-0.10
Q1 25
$0.00
$-0.17
Q4 24
$-0.05
$0.05
Q3 24
$0.12
$0.09
Q2 24
$-0.01
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MNTK
MNTK
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$23.8M
$91.4M
Total DebtLower is stronger
$126.0M
Stockholders' EquityBook value
$263.1M
Total Assets
$435.5M
$520.0M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MNTK
MNTK
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$23.8M
$93.7M
Q3 25
$6.8M
$63.7M
Q2 25
$29.1M
$73.1M
Q1 25
$40.1M
$110.0M
Q4 24
$45.6M
$135.6M
Q3 24
$55.0M
$94.3M
Q2 24
$42.3M
$89.9M
Total Debt
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
$126.0M
Q3 25
$54.9M
Q2 25
$57.8M
Q1 25
$40.8M
Q4 24
$43.8M
Q3 24
$46.7M
$62.3M
Q2 24
$49.7M
$63.8M
Stockholders' Equity
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
$263.1M
$300.1M
Q3 25
$260.7M
$255.1M
Q2 25
$254.7M
$233.2M
Q1 25
$258.2M
$242.9M
Q4 24
$257.4M
$262.9M
Q3 24
$275.3M
$278.5M
Q2 24
$255.3M
$263.5M
Total Assets
MNTK
MNTK
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$435.5M
$598.7M
Q3 25
$383.3M
$509.8M
Q2 25
$382.5M
$461.1M
Q1 25
$354.2M
$467.4M
Q4 24
$349.0M
$497.9M
Q3 24
$374.1M
$446.3M
Q2 24
$362.0M
$443.2M
Debt / Equity
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
0.48×
Q3 25
0.21×
Q2 25
0.23×
Q1 25
0.16×
Q4 24
0.17×
Q3 24
0.17×
0.22×
Q2 24
0.19×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MNTK
MNTK
ORGO
ORGO
Operating Cash FlowLast quarter
$337.0K
Free Cash FlowOCF − Capex
$-41.1M
FCF MarginFCF / Revenue
-94.7%
Capex IntensityCapex / Revenue
95.5%
Cash ConversionOCF / Net Profit
0.14×
TTM Free Cash FlowTrailing 4 quarters
$-86.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
$337.0K
$39.4M
Q3 25
$12.7M
$3.1M
Q2 25
$8.2M
$-32.9M
Q1 25
$9.1M
$-19.9M
Q4 24
$724.0K
$10.9M
Q3 24
$28.6M
$8.7M
Q2 24
$193.0K
$4.7M
Free Cash Flow
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
$-41.1M
$34.8M
Q3 25
$-17.2M
$844.0K
Q2 25
$-25.5M
$-36.5M
Q1 25
$-2.5M
$-23.6M
Q4 24
$-8.3M
$7.6M
Q3 24
$16.0M
$6.1M
Q2 24
$-18.6M
$2.9M
FCF Margin
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
-94.7%
15.4%
Q3 25
-37.9%
0.6%
Q2 25
-56.4%
-36.1%
Q1 25
-5.8%
-27.2%
Q4 24
-29.8%
6.0%
Q3 24
24.3%
5.3%
Q2 24
-42.9%
2.2%
Capex Intensity
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
95.5%
2.1%
Q3 25
65.9%
1.5%
Q2 25
74.6%
3.6%
Q1 25
27.3%
4.2%
Q4 24
32.5%
2.7%
Q3 24
19.1%
2.2%
Q2 24
43.3%
1.4%
Cash Conversion
MNTK
MNTK
ORGO
ORGO
Q1 26
Q4 25
0.14×
0.90×
Q3 25
2.43×
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
1.68×
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MNTK
MNTK

Natural Gas Environmental Attributes$28.1M65%
Natural Gas Commodity$10.7M25%
Electric Commodity$2.7M6%
Electric Environmental Attributes$2.0M5%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons